ClinicalTrials.Veeva

Menu

Efficacy of rTMS in the Treatment of Patients With Migraine

T

Taipei Veterans General Hospital

Status

Unknown

Conditions

Migraine

Treatments

Device: Repetitive Transcranial Magnetic Stimulation (rTMS)

Study type

Interventional

Funder types

Other

Identifiers

NCT00316979
rTMS_Migraine_VGHTPE

Details and patient eligibility

About

Migraine is a condition thought to be related to cortical hyperexcitability. Repetitive transcranial magnetic stimulation (rTMS) can modulate the cortical excitability by means of long-term potentiation or long-term depression. This study will will test the safety and efficacy of rTMS in the treatment of patients with Migraine.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age of 18-65 years
  • Diagnosed as migraine (with or without aura)
  • More than 4 attacks per month for at least 3 months prior to study
  • No preventive medication used
  • Must be able to sign permit

Exclusion criteria

  • History of seizure or family history of seizures
  • Women in pregnancy or breast-feeding
  • Patient with medication overuse
  • Patient with other medical, psychologic, or surgical illness
  • Patient under preventive medications
  • Prior rTMS examination one month within

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Central trial contact

Shuu-Jiun Wang, MD; Kuan-Lin Lai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems